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Abstract
Background: Soluble amyloid-b (Ab;) oligomers have been recognized to be early and key intermediates in
Alzheimer’s disease (AD)-related synaptic dysfunction. Ab oligomers block hippocampal long-term potentiation
(LTP) and impair rodent spatial memory. Wnt signaling plays an important role in neural development, including
synaptic differentiation.
Results: We report here that the Wnt signaling activation prevents the synaptic damage triggered by Ab
oligomers. Electrophysiological analysis of Schaffer collaterals-CA1 glutamatergic synaptic transmission in
hippocampal slices indicates that Wnt-5a increases the amplitude of field excitatory postsynaptic potentials (fEPSP)
and both AMPA and NMDA components of the excitatory postsynaptic currents (EPSCs), without modifying the
paired pulse facilitation (PPF). Conversely, in the presence of Ab oligomers the fEPSP and EPSCs amplitude
decreased without modification of the PPF, while the postsynaptic scaffold protein (PSD-95) decreased as well.
Co-perfusion of hippocampal slices with Wnt-5a and Ab oligomers occludes against the synaptic depression of
EPSCs as well as the reduction of PSD-95 clusters induced by Ab oligomers in neuronal cultures. Taken together
these results indicate that Wnt-5a and Ab oligomers inversely modulate postsynaptic components.
Conclusion: These results indicate that post-synaptic damage induced by Ab oligomers in hippocampal neurons is
prevented by non-canonical Wnt pathway activation.
Background
Wnts are a family of secreted proteins that bind to
Frizzled receptors to activate intracellular signaling cas-
cades, including the Wnt/b-catenin [1], Wnt/Ca
2+ [2]
and Wnt/planar cell polarity (PCP) pathways [3]. The
current classification of the Wnt pathways differentiate
between the “b-catenin dependent” and “b-catenin inde-
pendent” pathways. b-catenin independent or non-cano-
nical Wnt pathways include the activation of several
targets such as Protein Kinase C (PKC), Calcium Calmo-
dulin Kinase 2 (CaMKII) and Jun N-terminal Kinase
(JNK). Wnt-signaling controls neural patterning and dif-
ferentiation, including hippocampal formation, dendritic
morphogenesis, axon guidance and synapse formation
[4,5]. In fact, Wnt-3a modulates long-term potentiation
(LTP), suggesting a role for Wnt signaling in the regula-
tion of synaptic plasticity [6]. Small synthetic molecules
mimic Wnts leading to both increased spontaneous and
evoked neurotransmission that occurs in a transcrip-
tion-independent fashion [7]. We had previously showed
that Wnt-7a increases neurotransmitter release modulat-
ing the presynaptic component [8]. Deregulation of Wnt
signaling has been suggested as an etiological cause for
specific mental disorders. For example, Wnt signaling is
upregulated in schizophrenic brains [9] and b-catenin
levels were markedly reduced in Alzheimer’s disease
(AD) patients carrying autosomal dominant PS-1 inher-
ited mutations [10]. The amyloid-b-peptide (Ab)h a s
been shown to decrease b-catenin levels in cultured
neurons, interfering with normal Wnt signaling [11,12].
In the amyloid cascade hypothesis of AD, Ab neuro-
toxicity has its origin in the binding of Ab oligomers to
the post-synaptic region [13], or affecting vesicular
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any medium, provided the original work is properly cited.transmitter release [14-16]. Patients in the early stages
of AD present synaptic alterations [13,17], without clear
neuronal loss. Transgenic (Tg) mice with familial AD
mutations display disruptions of LTP that occur before
deposition of Ab plaques [18,19] and it is a sensitive
marker for early AD dysfunction. Evidence obtained in
neuronal cell cultures have shown that Ab directly affect
synaptic components including post synaptic protein 95
(PSD-95) [20,21]. PSD-95 is a scaffold protein that inter-
acts directly with N-methyl-D-aspartic acid receptors
(NMDARs), modulating their channel properties [22],
posttranslational processing [23] and stabilization at the
synapses [24]. Additionally, Snyder et al., [25] have
shown that the effect of Ab on endocytosis of NMDARs
is likely to contribute to the synaptic dysfunction
observed in AD [26]. Other studies have shown that
PSD-95 interacts indirectly with a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPARs)
through the transmembrane protein stargazin [27] and
regulates the trafficking and localization of AMPARs at
synapses [28]. We report here that Wnt-5a modulates
synaptic transmission by a postsynaptic mechanism,
which eventually is able to prevent the Ab synaptotoxi-
city triggered by the Ab oligomers.
Results
Wnt-5a increases synaptic amplitude of glutamatergic
transmission without affecting paired pulse facilitation in
hippocampal slices
To examine the effects of Wnt-5a on excitatory gluta-
matergic transmission evoked by stimulation of Schaffer
collaterals (SC) in hippocampal slices, we recorded the
field excitatory postsynaptic potentials (fEPSP) and the
excitatory postsynaptic currents (EPSCs) in the presence
of 10 μM picrotoxin (PTX) to block GABAA-mediated
inhibitory synaptic transmission. The fEPSP amplitude
increased after 20 min of Wnt-5a addition to Artificial
CerebroSpinal Fluid (ACSF) perfusion media, 57.5% ±
15.5 (p < 0.05; n = 6), without changing either the fiber
volley (fV) amplitude or paired pulse facilitation (PPF)
(Figure 1A and 1B). This effect was antagonized comple-
tely in the presence of anti-Wnt-5a,ag e n e r i ca n t i b o d y
again Wnt-5a domain [29], moreover, this Wnt-5a effect
was reversible after 20 min of washout (Figure 1A and
upper graphs)
To examine the contributions of non-NMDARs (i.e.:
AMPARs) and NMDARs in the Wnt-5a potentiation of
glutamatergic transmission, we recorded intracellulary
the EPSCs at different holding potentials in identified
CA1 pyramidal neurons (Figure 1C). In these experi-
ments, EPSCs evoked by the same stimulations started
immediately after entering whole-cell configuration while
the membrane potential (Vm) was held at -70 mV. In
order to reduce the contribution of postsynaptically
mediated plastic phenomena to the observed effects [30],
the EPSCs were obtained 20 min later while briefly clam-
pling the cell at both -90 and +40 mV (< 2 min). The per-
fusion of Wnt-5a increased the EPSCs amplitude evoked
at both values of Vm. The EPSCs mean values of
AMPARs and NMDARs components, measured at peak
and 200 ms after the stimuli respectively, showed an
increase of 35% at -90 mV and 48% at +40 mV with
respect to control ACSF (Figure 1C and left graph).
Under these conditions, the mean values of the PPF did
not change in the presence of Wnt-5a at both holding
potentials (Figure 1C and right graph). These results indi-
cate that the potentiation induced by Wnt-5a is due to
postsynaptic modulation of the glutamatergic postsynap-
tic currents mediated by activation of both NMDA and
AMPA receptors.
Ab oligomers reduce the amplitude of synaptic response
without affecting the PPF
The current hypothesis on AD suggests that the neuro-
toxic Ab specifically affects central synapses, in the form
of Ab oligomers [13,20]. Ab oligomers associate with
regions enriched in PSD-95 [20] and reduce the PSD-95
content in both hippocampal neurons [21] and APP trans-
genic animals [26]. We confirmed such studies and asked
whether the Wnt-5a activation of the non-canonical path-
way is able to overcome the neurotoxic effect of Ab oligo-
mers. To examine the effects of Ab oligomers on
excitatory glutamatergic transmission in the CA3-CA1
synapses, we recorded fEPSP. The fEPSP amplitude
decreased after 20 min of adding 500 nM Ab to the ACSF
perfusion media (Figure 2A), without changing either the
fV amplitude (data non-shown) or PPF (Figure 2A). This
effect was partially reversible after 20 min of washout (Fig-
u r e2 A ) .O na v e r a g e ,A b induces a decrease of 47% ± 10
of fEPSP amplitude (p < 0.05; n = 5), (Figure 2B, left
graph), without affecting facilitation. In fact, mean values
of the PPF did not change significantly with respect to
their controls in any of these conditions (Figure 2B, right
graph). The hippocampal slices treated with Ab fibrils
(500 nM) showed no effects on either the amplitude or
facilitation (Figure 2E and 2F). Additional file 1A shows an
additional control, using reverse peptide Ab42-1 amplitude
of fEPSP. No changes with respect to the baseline were
observed.
The intracellular recording experiments carried out
using the same condition as that the field potentials
confirmed that Ab oligomers affect the amplitude of the
response without affecting the facilitation index. The
effect of Ab oligomers on EPSCs and PPF are showed
before (baseline) and 40 min after the application of the
Ab oligomers (Figure 2C). The normalized amplitude of
the response was 60% less after of application of Ab oli-
gomers compared to baseline (Figure 2D, left graph).
The mean facilitation index values of do not change in
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Page 2 of 13the presence of Ab oligomers (Figure 2D, right graph).
No changes in the PPF indicate that the probability of
neurotransmitter release does not change in presence of
Ab and thus that synaptic depression could be due to
postsynaptic mechanisms.
Ab oligomers reduce both NMDA and AMPA postsynaptic
currents
Previous evidence has shown that removal of AMPARs
is necessary and sufficient to induce the Ab-mediated
synaptic depression [31]. To test whether NMDARs and
AMPARs showed different sensitivities to Ab oligomers,
we compared their effects on SC (Shaffer Collaterals)
evoked current by clampling the neuron at both +40
and -80 mV, in the presence of the glutamate receptor
antagonists DL-2-amino-5-phosphonovaleric acid (50
μM APV) and 6-cyano-7-nitroquinoxaline-2,3-dione (20
μM CNQX), respectively. In the presence of CNQX, the
EPSCs at -80 mV were completely abolished, while at
+40 mV were reduced until a 65% respect to control
ASCF (Figure 3A). Under these conditions, perfusion of
500 nM Ab oligomers decreased the NMDARs-
mediated-response, reaching only 27% of the control
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Figure 1 Field Potential and Intracellular recording of CA1 pyramidal neurons after Wnt-5a treatment. (A, left), Superimposed, average
(10 sweeps) of field potentials (fEPSPs) recorded from stratum radiatum of CA1 region before (a), after 30 min of Wnt-5a perfusion (b) and 20
min of washout (c). (A, right), Superimposed, normalized (to R1), averaged (10 sweeps) fEPSPs evoked by paired pulse stimulation (100 ms delay)
in baseline and in presence of Wnt-5a (a+b). (A, middle), Time course of effect of Wnt-5a (black burbles) or Wnt-5a plus anti-Wnt-5a (white
burbles) on fEPSPs peak amplitudes. Bottom, effect of Wnt-5a plus anti-Wnt-5a on fV. (B), Normalized amplitude of fEPSPs, evoked by the first
stimulus (top), in control and after Wnt-5a or Wnt-5a plus anti-Wnt-5a treatment after 50 min of continued perfusion. Average values of
normalized amplitude of fiber volley are shown (center), measured before (control) and after Wnt-5a (n = 6) or Wnt-5a plus Anti-Wnt-5a (n = 4)
treatment application. Index of facilitation in both conditions (botton). (C, left), Superimposed, average EPSCs (20 sweeps) evoked by single
stimulus and paired pulse stimulation at -90 and +40 mV of holding potential in control conditions (gray trace) and in the presence of Wnt-5a
(black trace), respectively. (C, right) Summary data of average, normalized EPSCs amplitude and facilitation index, obtained in C in baseline and in
the presence of Wnt-5a (n = 6), respectively. Bar represents the mean ± SEM (*p < 0.05 Student’s t test).
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Page 3 of 13EPSC ASCF amplitude. In the presence of APV, the
EPSCs amplitude and decay constants (data non shown),
measured at both -80 and +40 mV holding potentials
were diminished with respect to control ASCF (Figure
3B). The addition of Ab oligomers reduced the
AMPARs-mediated-response reaching only 75% of the
EPSC control ASCF amplitude. On average, in the pre-
sence of Ab oligomers the mean values of EPSCs
r e s p o n s e sm e d i a t e db yN M D A R s( i . e . :C N Q Xa n d+ 4 0
mV; n = 6) were significantly lower than AMPARs (i.e.:
A P Va n d- 8 0m V ;n=5n e u r o n s )( F i g u r e3 C ) .T h e
above results show that the synaptic depression induced
by Ab oligomers affects the NMDAR more than the
AMPAR receptors.
Wnt-5a occludes the depression induced by Ab Oligomers
on Synaptic Transmission
The evidence shows that Wnt-5a augments the glutama-
tergic transmission mainly by a postsynaptic mechanism
increasing both NMDA and AMPA currents.
Conversely, Ab oligomers impair synaptic transmission
mainly by decreasing the NMDA currents and to a
smaller degree the AMPA currents. Therefore, in order
to examine whether Wnt-5a treatment prevents Ab oli-
gomer induced synaptic impairment, we treated the hip-
pocampal slices with Wnt-5a i nt h ep r e s e n c eo fA b
oligomers (Figure 4A, first arrow), and later with Ab oli-
gomers alone (Figure 4A, second arrow). Under these
conditions, Wnt-5a showed protective effects against Ab
oligomers, without changing the EPSCs amplitude. In
t h es a m es e to fe x p e r i m e n t s ,i nt h ep r e s e n c eo fA b oli-
gomers alone, the removal of Wnt-5a from the perfu-
sion media decreased the EPSCs amplitude around 60%
at a holding potential of -80 mV (Figure 4B and 4C). In
both conditions, the facilitation index did not show any
change compared to control, confirming that it is the
postsynaptic site where the effects of both peptides take
place (Figure 4C). Additionally, we carried out experi-
ments adding Ab oligomers alone, waiting 30 min to
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Figure 2 Ab oligomers but not Ab fibrils reduce the amplitude of fEPSP without affect the PPF. (A, left), Superimposed, average (10
sweeps) of fEPSPs before (a) and after 40 min of Ab oligomers perfusion (b). (A, right), Superimposed, normalized (to R1), averaged (10 sweeps)
fEPSPs evoked by paired pulse stimulation (100 ms delay) in control and in presence of Ab oligomers (a+b), and time course of Ab oligomer
effects on fEPSPs. a) baseline, b) effect of Ab oligomers and c) washout with ACSF. (B) Summary data of fEPSPs amplitude (left) and facilitation
index in control and after Ab oligomers treatment. (n = 5). (C) Superimposed, average (10 sweeps) of EPSCs evoked by single and paired pulse
protocol, before (control, gray trace) and after 40 min of continued perfusion with Ab oligomers (black trace). (D) Summary date of EPSCs
amplitude (right) and facilitation index (left) in control and after Ab oligomers treatment, respectively. (n = 5). (E) Superimposed, normalized (to
R1), averaged (10 sweeps) fEPSPs evoked by paired pulse stimulation in control and in presence of Ab fibrils. (F), Summary date of fEPSPs
amplitude (left) and facilitation index (right) in control and after Ab fibrils treatment (n = 4). Bar represents the mean ± SEM (*p < 0.05 Student’s
t test).
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Page 4 of 13observe the effect, and then allowing that Wnt-5a
recovers the levels of amplitude of fEPSP (Additional
file 1B).
Ab oligomers reduce the surface expression of gluta-
mate receptors [25], hence, we examined whether the
activation of the non-canonical Wnt-5a signaling was
able to protect PSD-95 from the synaptotoxic effects of
Ab oligomers. When hippocampal neuron cultures were
exposed to Ab oligomers, a major decrease in PSD-95
clusters was observed. However, co- incubation of Ab
oligomers with Wnt-5a showed that the distribution of
the PSD-95 was similar to control neurons (Table 1).
Co-treatment with the Wnt antagonist soluble frizzled
receptor protein (sFRP-1) abolished the increase of
PSD-95 triggered by Wnt-5a (Table 1). Figure 5A shows
the species of Ab oligomer used in this study which cor-
responds to Ab oligomers [32]. We evaluated by Wes-
tern blots the total level of PSD-95 protein. Ab
oligomers decrease PSD-95 levels, while the co-incuba-
tion with Wnt-5a prevented such changes (Fig. 5B).
Additionally, we determined that Ab oligomers do not
affect the levels of Wnt-5a in 15DIV neurons, but do
decrease neuronal ramifications, as measured MAP-2
staining. However in these ramifications the levels of
Wnt-5a did not change (Additional file 2A). In the addi-
tional file 2B, we determined the levels of Wnt-5a in
cellular medium, and in conditioned medium used in
the treatments.
Moreover, we evaluated whether Wnt-5a prevents the
loss of synaptic contacts induced by Ab oligomer treat-
ment. We quantified the number of synaptic PSD-95
opposite to total synapsin-1 clusters and found that Ab
oligomers decreased the contact between pre-synaptic
and post-synaptic regions by almost 55% (Figure 5C),
more details in figure 6A. The quantification of PSD-95
and Synapsin is showed in figure 6B. Hippocampal neu-
rons treated with Ab oligomers in the presence of the
Wnt-5a ligand did not show any loss of synaptic con-
tacts. The total levels of synapsin did not change (Addi-
tional file 3A). In fact, an increase of almost 40% with
respect to the effect observed for the Ab treatment
a l o n ew a so b s e r v e di nt h ep r e s e n c eo ft h eWnt-5a
ligand (Figure 5C), and this effect was abolished by co-
treatment with the Wnt antagonist sFRP (Figure 5C).
On the other hand, we quantified synaptic PSD-95 in
relation to total PSD-95 cluster number. The results
indicate that Ab oligomers decrease the interaction
between the pre- and post-synaptic regions, since few
PSD-95 clusters remained following Ab treatment and
around 40-50% reduction in the PSD-95-synapsin inter-
action with respect to the total PSD-95 were observed.
Wnt-5a prevents the effect triggered by Ab oligomers at
the level of the synaptic structure (Figure 5D and 5E),
and the Wnt antagonist sFRP abolished the neuropro-
tective effect of Wnt-5a (Figure 5D and 5E). These
results show that the changes in the scaffold protein
PSD-95 levels induced by the Ab oligomers are pre-
vented by the activation of the non-canonical Wnt-5a
signaling pathway.
Discussion
Wnt signaling is essential for neuronal development and
the maintenance of the nervous system [12,33-35], includ-
ing hippocampal formation, dendritic morphogenesis,
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Figure 3 Ab oligomers decrease mainly the NMDA current.( A )
Average (20 sweeps) EPSCs in control (left), after treatment with
CNQX (gray trace) or CNQX plus Ab oligomers (black trace) (right) at
-80 and +40 mV of holding potential obtained from a same neuron.
B) Average (20 sweeps) EPSCs in control (left), after treatment with
APV (gray trace) or APV plus Ab oligomers (black trace) (right) at -80
and +40 mV of holding potential. C) Summary data of normalized
amplitude (to control) of evoked EPSCs obtained from experiments
on A (n = 6) and B (n = 5). Bar represents the mean ± SEM (*p <
0.05 Student’s t test).
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Page 5 of 13Figure 4 Wnt-5a occludes the synaptic transmission depression induce by Ab oligomers. (A), Time course of the treatment with Ab plus
Wnt-5a (first arrow) and to extra treatment with Ab oligomers (second arrow). (B), Average (20 sweeps) EPSCs in control (light gray), after 40 min
of treatment with Ab plus Wnt-5a treatment (black) and after to extra treatment with Ab oligomers (dark gray), recorded at -80 mV holding
potential. Mean of normalized amplitude of evoked EPSCs in control, Ab and Ab plus Wnt-5a treated slices (right) (n = 6). (C), Superimposed,
average EPSCs evoked by paired pulse test at +40 and -80 mV of holding potential (left). Mean of facilitation index measured before (control)
and after Wnt-5a plus Ab or Ab alone treatment application (right). Bar represents the mean ± SEM (*p < 0.05 Student’s t test).
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Page 6 of 13axon guidance and synapse formation [4,5]. When the
neuronal adult circuits are formed Wnt probably plays a
maintenance role in synaptic connectivity. Synaptic activity
cause releases of Wnt-3a from synapses and modulates
LTP, while inhibition of Wnt signaling impairs LTP, and
activation of Wnt signaling potentiates LTP [6], revealing
as y n a p t i cr o l ef o rWnt signaling in the regulation of the
synaptic efficacy in the neuronal adult circuit. Additional
evidence shows that modulation of Wnt signaling, by a
canonical Wnt-3a ligand, results in acute enhancement of
excitatory transmission in the hippocampus, through a
mechanism that might not necessarily involve the tran-
scriptional activity of μ-catenin complexes in the adult
CNS [7]. The same authors show that small molecule
modulators increase LTP, controlling excitatory transmis-
s i o n .H e r ew es h o w e dt h a tWnt-5a enhances the excita-
tory transmission. Both fEPSP and EPSCs amplitude,
increase in response to Wnt-5a treatment in the
CA3-CA1 hippocampal circuit. This effect is mainly due
to the NMDA current present in the hippocampal slices.
For this reason, and knowing the possible effect of Ab oli-
gomers in NMDA transmission [36,37], we analyzed the
possible protective effect of Wnt-5a against the Ab oligo-
mer induced synaptic damage. The synaptic damage
induced by Ab oligomer is considered central in the Alz-
heimer synaptic failure hypothesis. This hypothesis sup-
ports the idea that Ab causes “synaptic failure” before
plaques develop and neuronal death occurs [13]. An
important decrease has been demonstrated in the immu-
noreactivity of the protein synapsin-1 [38] which it has
also been observed in AD patients, in which synaptophysin
levels are diminished from the early stages of the disease
[39]. Furthermore, neurons from APP transgenic mice
exhibit decreased PSD-95 levels as well as dendritic spine
loss [18,26]. Our electrophysiological experiments show
that Ab oligomer treatments decrease synaptic efficacy,
which can be explained by the decreased levels of the
PSD-95 observed in hippocampal neuron cultures. We
characterize this process by measuring the effect of acute
Ab oligomers application on fEPSPs. This effect was
reversible after washing the Ab oligomers and did not
affect the presynaptic machinery of neurotransmitter
release. These results suggest that Ab oligomers mainly
affect the postsynaptic region [40]. Others studies have
shown that this synaptic damage is produced because
Ab oligomers could affect synaptic components including
the PSD-95, by a mechanism that involve the proteasome
pathway [20,21]. This decrease in PSD-95 has been related
to a reduction in the levels of the GluR1 subunit of the
AMPA-glutamate receptors in primary cultures of APP
mutant neurons, compared with neurons of wild-type
mice [26]. Another report showed that Ab formation and
secretion can be controlled by neuronal activity and
secreted Ab might depresses excitatory synaptic transmis-
sion in a NMDA receptor dependent activity [36,37].
Interestingly, EPSCs mediated by NMDARs in slices trea-
ted with Ab oligomers were more affected than the EPSCs
mediated by AMPARs, recorded in presence of CNQX
and APV, respectively (Figure 3). These findings suggest
that Ab oligomers promote the endocytosis of NMDA and
AMPA channels, as it has been reported in hippocampal
[31] and cortical neurons [25]. Also, Ab oligomers dimin-
ished the NMDA current and decreased the CREB tran-
scriptional factor required for LTP, memory and lifespan
[25]. In the synaptic context, it was recently described that
the cellular prion protein (PrP(C)) is a mediator of Ab-
oligomer-induced synaptic dysfunction, because Ab oligo-
mers bind with nanomolar affinity to PrP(C). Synaptic
responsiveness in hippocampal slices from young adult
PrP null mice is normal, but the Ab oligomer blockade of
LTP is absent. Anti-PrP antibodies prevent Ab-oligomer
binding to PrP(C) and rescue synaptic plasticity in hippo-
campal slices from oligomeric Ab [41].
The impairment produce by Ab mainly affects the
post-synaptic site, including a decrease in PSD-95 levels
[20] and glutamatergic channels (AMPARs [26] and
NMDARs [36,37]). In our studies Wnt-5a modulates the
synaptic transmission by a post-synaptic mechanism,
indicating that the activation of the non-canonical Wnt
pathway might protect from the Ab synaptic damage.
Downstream of the Wnt ligand exists several options to
activate the non-canonical pathways. These include the
activation of Frizzled and Dvl which in turn can activate
different kinases including PKC, CaMKII and JNK. Con-
cerning the last target in the pathway, JNK, our labora-
tory recently described that Wnt-5a/JNK pathway
modulates the post-synaptic region of mammalian
synapse directing the clustering and distribution of the
physiologically relevant scaffold protein, PSD-95 [42].
A second option of activation might involves the new
Wnt receptor Ror2 [43,44]. The activation of PKC could
directly modulate the phosphorylation of the NR1
NMDA subunits and induce its localization at the
synaptic membrane [45]. Other options include the
Table 1 Wnt-5a ligand induces the clustering of PSD-95,
effect of Ab oligomers: Immunofluoresce in mature
hippocampal neurons of 21DIV, every treatment were by
1h .
Treatments PSD-95 (Number of clusters in 100 μM of neurite)
Control 24 ± 3
Wnt-5a 46 ± 8*
Wnt-5a/sFRP 25 ± 4
Ab 9±3 *
Ab/Wnt-5a 23 ± 2
Ab/Wnt-5a/sFRP 11 ± 2*
Ab 1 μM, (n = 3). *P < 0.01 respect to the control
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Page 7 of 13Figure 5 Wnt-5a prevents the changes induced by Ab oligomers on PSD-95 clustering and in synaptic contact. (A) Electron micrograph
of the material corresponding to Ab-oligomers taken in Phillips Tecnai 12 EM. The picture shows the amylospheroids. Scale bar = 100 nm. (B)
Representative immunoblot of total PSD-95 levels of neurons exposed to 0.05 or 0.5 μMA b oligomers in the presence or absence of Wnt-5a and
a quantification of densitometry are shown (n = 3). *P < 0.05. (C), Representative neurite images of double immunofluorescence of PSD-95
(green) and synapsin-1 (red) and stained with phalloidin (blue) from samples subjected for 1 h to control, Ab,A b/Wnt-5a and Ab/Wnt-5a/sFRP
treatments. Merged images show the apposition of the pre-synaptic (red) and post-synaptic (green) boutons. (D), Quantification of synaptic PSD-
95 over total synapsin-1 and; (F), quantification of synaptic PSD-95 over total PSD-95 upon the different treatments used in C (n = 4). Bar
represents the mean ± SEM (*p < 0.05 Student’s t test).
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Page 8 of 13Figure 6 Wnt-5a prevents the changes induced by Ab oligomers in the synaptic contact.(A), Representative neurite images of double
immunofluorescence of PSD-95 (green) and synapsin-1 (red), from samples subjected for 1 h to control, Ab,A b/Wnt-5a and Ab/Wnt-5a/sFRP
treatments. Merged images show the apposition of the pre-synaptic (red) and post-synaptic (green) boutons. (B), Quantification of the number
of clausters of the figure A (n = 3). Bar represents the mean ± SEM (*p < 0.05 Student’s t test).
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Page 9 of 13modulation of CaMKII activity and the incorporation of
NMDARs in the synapse. Also the activation of JNK
could modulate the actin cytoskeleton and produce a
remodeling in the dendritic spines structures [46]. All
these options imply that Wnt is preparing the synapses
for defense against possible injury and probably its effect
on synaptic, PSD-95 is the most important factor player
modulated by Wnt in controlling the Ab damage. We
reasoned that when the Ab treatment occurs in the hip-
pocampal slices in the presence of Wnt-5a synaptic
impairment is prevented.
Conclusion
These results suggest that the Wnt-5a plays a pivotal
role in the maintenance of normal postsynaptic integrity,
and its activation may be of therapeutic interest in
patients with neurodegenerative diseases such as AD.
Methods
Reagents
Synthetic Ab1-40 peptide corresponding to the human
Ab w i l d - t y p es e q u e n c ea n dt h eA b1-42 artic variant [32]
were obtained from Chiron Corp. Inc., (Emeryville, CA)
and Calbiochem (Postfach, Germany). Antibodies for
Synaptic Proteins from Santa Cruz Biotechnology Inc.
Immunostaining was also carried out using polyclonal
anti-PSD-95, Synapsin-1 and secondary antibody
labelled with
488Alexa,
543Alexa or
633Alexa (Affinity Bio
Reagents Inc., Golden, CO). To study neuronal mor-
phology phalloidin labelled with TRITC from Molecular
Probes (Leiden, The Netherlands) was used.
Wnt constructs
The different HA-Wnt or sFRP-1 constructs were a kind
gift of several individuals, which really made this work
possible. Wnt-5a was a gift of Dr. Randall T. Moon,
University of Washington, Seattle, WA; and sFRP-1 was
a gift of Dr. Jeremy Nathans, Johns Hopkins University
School of Medicine, Baltimore, MD.
Cell line culture
Human embryonic kidney 293 cells (HEK-293) were
maintained in DMEM supplemented with 10% fetal calf
s e r u m( G i b c oB R L ,R o c k v i l l e ,M D ) ,a n d1 0 0u g / m l
streptomycin and 100 U/ml penicillin.
Conditioned medium containing Wnt ligands
Wnt ligands were generated in HEK-293 cells transiently
transfected by calcium phosphate precipitation [47] with
constant and equal amounts of empty vector pcDNA or
pcDNA containing the sequences encoding Wnt-5a con-
structs. Wnt-conditioned or control media or media
containing sFRP-1 were prepared as described [11,48].
Wnt secretion was verified by Western blot using an
anti-HA antibody (Upstate Biotechnology, Lake Placid,
NY) (additional file 3B).
Primary Rat embryo hippocampal neuron cultures and
treatments
Rat primary hippocampal neurons were prepared as pre-
viously described [8,11,49]. Hippocampal neurons were
obtained from 14 to 21-day-old Sprague-Dawley rat
embryos. On day 3 of culture, hippocampal neurons
were treated with 1 μM1 - b-D-arabinofuranosylcytosine
for 24 h in order to reduce the number of proliferating
non-neuronal cells.
Ab Oligomers Preparation and Electron Microscopy
The artic Ab1-42 peptide [32] was dissolved in anhydrous
and sterile DMSO at 15 mg/ml concentration. For oligo-
mer formation, one aliquot was dissolved in 0.5% PBS at
50 mM final concentration. The sample was subjected
to a basic shock adding 2N NaOH to reach pH 12.
Then, the sample was neutralized with 1N HCl. The
mixture was incubated at room temperature under con-
stant agitation during 1 h to obtain the Ab oligomers.
To visualize Ab oligomers by electron microscopy, sam-
ples were treated as described before [50], and observed
using a Phillips Tecnai 12 electron microscope.
Western Blot
Total protein was prepared from primary rat hippocam-
pal neurons lysed in a buffer RIPA (50 mM Tris-Cl, 150
mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and
0.1% SDS) supplemented with a protease inhibitor mix-
ture. Equal amounts of protein were resolved using
SDS-PAGE, proteins were transferred to PVDF mem-
branes, and immunoblots using anti- PSD-95 and anti-
tubulin (Sta Cruz, Biotec. Inc) antibodies.
Immunohistochemistry
Hippocampal neurons were subjected to different treat-
ments while on coverslips within 24-well plates at a
plating density of 30,000 cells/coverslip, fixed with 4%
paraformaldehyde/4% sucrose in PBS for 20 min, per-
meabilized with 0.2% Triton X-100 for 5 min, blocked
with 0.2% gelatin and stained with PSD-95 and Synap-
sin-1 antibodies. Phalloidin coupled to Alexa 633 was
used as neurite marker. Digital images of neurons on
coverslips were captured with a Zeiss confocal micro-
scope. Images used for quantification were taken with
identical microscope settings and analyzed using Image
J software (NIH).
Double antibody sandwich ELISA Techniques
96 wells plates were coated with anti-Wnt-5a antibody
(Sta Cruz, Biotec. Inc) first antibody antigen capture, the
conditioned media the different cultures was concen-
trated with Amicon tubes and incubated for 1 hr at 37°
C. The ligand detection was made with a second mono-
clonal antibody (R&D Sistem) against Wnt-5a ligand.
The detection of reaction was made with ABC KIT
(Vectastain System, Vector Laboratories, CA. USA) and
OPD as substrate.
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Page 10 of 13Slice preparation and Electrophysiology
Hippocampal slices were prepared essencially as
described previously [8]. Then, slices were transferred to
an experimental chamber (2 ml), superfused (3 ml/min,
at 22-26°C) with gassed ACSF. The experiments were
carried out at room temperature (21°C-22°C), measured
at the recording chamber. Two recording methods were
used: patch clamp [51] and extracellular field potentials
recording [52]. Single cell recording were made in the
whole-cell configuration with fire-polished pipettes (3-5
MΩ) filled with intracellular solution (see below), con-
nected to a tight seal (>1 GΩ). Whole-cell recordings
were obtained from the cell body of neurons in the CA1
pyramidal layer. Patch electrodes were made from boro-
silicate glass and had a resistance of 2-5 MΩ when filled
with (in mM); 97.5 K-Gluconate, 32.5 KCl, 10.0 4-(2-
hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES),
1.0 MgCl2, 5.0 ethyenebis-(oxonitrilo) tetracetate
(EGTA) and 4.0 sodium salt (Na-ATP); pH 7.2 (289
mOsm). Neurons were voltage clamped with an EPC-7
amplifier (Heka Instruments), and the experiments
started after a 5-10 min stabilization period after access
to the intracellular compartment with patch electrodes.
The access resistance (10-25 MΩ)w a sm o n i t o r e da n d
cells were rejected if it changed more than 20% during
the experiment. Extracellular field potentials recording
[53] were made with a glass pipettes (2-4 MΩ, filled
with the perfusion medium), connected to an A.C.
amplifier (P-5 Series, Grass), with gain 10000×, LP filter
3 . 0k H za n dH Pf i l t e r0 . 3 0H z ,t h a tw a sp l a c e di nt h e
middle of stratum radiatum of CA1, exactly as described
before [8]. The PPF index was calculated by ((R2-R1)/
R1), were R1 and R2 are the peak amplitudes of the first
and second EPSCs, respectively. Recordings were filtered
at 2.0-3.0 kHz, sampled at 4.0 kHz using an A/D con-
verter (ITC-16, Intrutech), and stored with Pulse FIT
software (Heka Instruments).
Statistical analysis
Data were expressed as the mean ± SEM of the values
from the number of experiments as indicated in the cor-
responding figures. Data were evaluated statistically by
using the Student’s t-test, with P < 0.05 considered sig-
nificant. ANOVA test was used to compare n differ-
ences between experiments.
Additional file 1: (A), Time course of effect of Ab42-1 (gray circles)
on fEPSPs peak amplitudes (n = 4). (B), Time course of effect of Ab
oligomers and Wnt-5a after (gray circles) on fEPSPs peak amplitudes (n =
3).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-1326-5-3-
S1.PPT]
Additional file 2: Detection of Wnt-5a Ligand under action of Ab
oligomers. Neurons 15 DIV of culture were treated with Ab oligomers
for an hour and were immunostained for MAP2 protein and Wnt-5a
ligand. (A), Show representative image to MAP, a: control neurons, b:
Neurons treated with Ab oligomers 50 nM, c: Neuron treated with Ab
500 nM. Neuron was inmunostain with a specific antibody against Wnt-
5a ligand, .d: Control Neurons, e: Neurons treated with Ab oligomers 50
nM, f: Neuron treated with Ab 500 nM, g: The graphs show fluorescence
intensity for Wnt-5a ligand on neuron. Results are the mean ± S.E.M, in
duplicate experiments, n = 3 separate experiments. Student’s t-test *p <
0.050. (B), The soluble Wnt-5a ligand was detected in culture media for
Hippocampal neurons 15 DIV by Sandwich ELISA technique under effect
of Ab oligomers.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-1326-5-3-
S2.PPT]
Additional file 3: (A), Representative immunoblot of total synapsin-
1 levels of neurons exposed to Ab oligomers in the presence or
absence of Wnt-5a and a quantification of densitometry are shown
(n = 3). (B), Representative immunoblot of total HA-Wnt-5a levels of
HEK-293 cells producing conditional medium.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1750-1326-5-3-
S3.PPT]
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